Citation Impact
Citing Papers
Implications of time‐series gene expression profiles of replicative senescence
2013
Role of Genotype in the Cycle of Violence in Maltreated Children
2002 StandoutScience
4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1
2007 StandoutNobel
Signal integration in the endoplasmic reticulum unfolded protein response
2007 Standout
Oxidative Stress and Genetics in the Pathogenesis of Parkinson's Disease
2000
A Role for 12-lipoxygenase in Nerve Cell Death Caused by Glutathione Depletion
1997
Effect of Buthionine Sulfoximine, a Synthesis Inhibitor of the Antioxidant Glutathione, on the Murine Nigrostriatal Neurons
1996
Neurotrophic factors in Alzheimer’s and Parkinson’s disease brain
2000
Merkel Cells Activate Sensory Neural Pathways through Adrenergic Synapses
2018 StandoutNobel
Memantine in Moderate-to-Severe Alzheimer's Disease
2003 Standout
Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures
1995
Treatment of extrapyramidal side effects with terguride
1992
Vascular dementia
2015 Standout
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
The Glutathione System of Peroxide Detoxification Is Less Efficient in Neurons than in Astroglial Cells
1999
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
1998 StandoutNature
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
2002 Standout
Hydrogen peroxide mediates amyloid β protein toxicity
1994 Standout
Neuropeptides, amines and amino acids in an elementary insect ganglion: Functional and chemical anatomy of the unfused abdominal ganglion
1996
Neurotrophic Effects of l ‐DOPA in Postnatal Midbrain Dopamine Neuron/Cortical Astrocyte Cocultures
1997
Drug-Induced Hepatotoxicity
2003 Standout
Balancing Acts
2004 Standout
Aging, energy, and oxidative stress in neurodegenerative diseases
1995
A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes
2002
Intervention strategies to inhibit protein carbonylation by lipoxidation‐derived reactive carbonyls
2006
Partial dopamine receptor agonists reverse behavioral, biochemical and neuroendocrine effects of neuroleptics in the rat: Potential treatment of extrapyramidal side effects
1993 StandoutNobel
Protection of PC12 cells by glutathione peroxidase in L-DOPA induced cytotoxicity
1998
Neuromelanin in human dopamine neurons: Comparison with peripheral melanins and relevance to Parkinson's disease
2005
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease
1994
Nrf2-induced antioxidant protection: A promising target to counteract ROS-mediated damage in neurodegenerative disease?
2008
Free radicals in Alzheimer’s disease
1998
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics
1990 StandoutNature
Contributory mechanisms in the causation of neurodegenerative disorders
1993
The Relevance of Iron in the Pathogenesis of Parkinson's Disease
2004
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
2012 Standout
Parkinson's disease
2015 Standout
Hereditary ceruloplasmin deficiency with hemosiderosis: A clinicopathological study of a japanese family
1995
Oxidative stress in Parkinson's disease
2003 Standout
Dopamine transporters and neuronal injury
1999
Immunocytochemical demonstration of reduced glutathione in neurons of rat forebrain
1999
Neuroprotective and symptomatological action of memantine relevant for alzheimer’s disease — a unified glutamatergic hypothesis on the mechanism of action
2000
Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist—a review of preclinical data
1999
Zinc Metabolism in the Brain: Relevance to Human Neurodegenerative Disorders
1997
Vitamin E, Ascorbate, Glutathione, Glutathicne Disulfide, and Enzymes of Glutathione Metabolism in Cultures of Chick Astrocytes and Neurons: Evidence that Astrocytes Play an Important Role in Antioxidative Processes in the Brain
1994
Analysis of glutathione: implication in redox and detoxification
2003
Terguride in Parkinsonism a multicenter trial
1988
Glutathione, oxidative stress and neurodegeneration
2000
From endoplasmic-reticulum stress to the inflammatory response
2008 StandoutNature
The Role of Iron and Copper in the Aetiology of Neurodegenerative Disorders
2002
Impulsivity as a vulnerability marker for substance-use disorders: Review of findings from high-risk research, problem gamblers and genetic association studies
2008 Standout
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Programmed Cell Senescence during Mammalian Embryonic Development
2013 Standout
Role of mitochondria in the etiology and pathogenesis of Parkinson's disease
1995
Hypothesis: Can N-acetylcysteine be beneficial in Parkinson's disease?
1999
The Role of Iron in Neurodegeneration
1999
The relevance of iron in the pathogenesis of Parkinson’s disease
2010
The comparative biology of neuromelanin and lipofuscin in the human brain
2008
Metabolism and functions of glutathione in brain
2000 Standout
A review of central 5-HT receptors and their function
1999 Standout
Involvement of Endoplasmic Reticulum Stress on the Cell Death Induced by 6-Hydroxydopamine in Human Neuroblastoma SH-SY5Y Cells
2006
Parkinson's Disease
1998 Standout
Iron-binding characteristics of neuromelanin of the human substantia nigra
2003
Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease
2002
Neuroinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention
2007
Review: D1 dopamine receptor—the search for a function: A critical evaluation of the D1/D2 dopamine receptor classification and its functional implications
1987
Interaction of neuromelanin and iron in substantia nigra and other areas of human brain
1996
Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia
1994
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
Glial Cells Mediate Toxicity in Glutathione‐Depleted Mesencephalic Cultures
1999
Alzheimer's Disease
2004 Standout
Oxidative stress: Free radical production in neural degeneration
1994
Oxidative stress in ALS: A mechanism of neurodegeneration and a therapeutic target
2006
Disorders of Iron Metabolism
1999 Standout
The importance of glutathione in human disease
2003 Standout
Oxidative stress and neurodegenerative disorders
1998
Glutathione‐related enzymes in brain in Parkinson's disease
1994
Neuromelanin associated redox‐active iron is increased in the substantia nigra of patients with Parkinson's disease
2003
Parkinson's Disease
2003 Standout
Differential Regulation of Dopamine D1A Receptor Responsiveness by Various G Protein-coupled Receptor Kinases
1996 StandoutNobel
The Antioxidant Ebselen Prevents Neurotoxicity and Clinical Symptoms in a Primate Model of Parkinson's Disease
2000
Modeling neurodevelopmental disorder-associated humanAGO1mutations inCaenorhabditis elegansArgonautealg-1
2024 StandoutNobel
Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling
2011 Standout
Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations
1995
Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour.
2001
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Copper Active Sites in Biology
2014 Standout
Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis
2016 Standout
Luminescent Chemodosimeters for Bioimaging
2012 Standout
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)
2006 Standout
Fluorescence Lifetime Measurements and Biological Imaging
2010 Standout
Efficacy and Safety of Memantine in Patients With Mild to Moderate Vascular Dementia
2002
Regulation of Antioxidant Metabolism by Translation Initiation Factor 2α
2001
Oxidative Damage to Mitochondrial Complex I Due to Peroxynitrite
2003 Nobel
ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE
1999
Role of Quinones in Toxicology
2000 Standout
Hippocampal Free Amino Acids in Alzheimer's Disease
1980
Abnormalities of Male-Specific FRU Protein and Serotonin Expression in the CNS offruitlessMutants inDrosophila
2001 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Fluorescent Chemosensors Based on Spiroring-Opening of Xanthenes and Related Derivatives
2011 Standout
A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone
2010 Standout
Specialized Membrane Domains for Water Transport in Glial Cells: High-Resolution Immunogold Cytochemistry of Aquaporin-4 in Rat Brain
1997 StandoutNobel
MONOAMINE OXIDASE: From Genes to Behavior
1999
Organoselenium and Organotellurium Compounds: Toxicology and Pharmacology
2004 Standout
Proteostasis Failure in Neurodegenerative Diseases: Focus on Oxidative Stress
2020
Metals in Neurobiology: Probing Their Chemistry and Biology with Molecular Imaging
2008 Standout
Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation
1983 StandoutScience
Oxidative stress in neurodegeneration: cause or consequence?
2004 Standout
Synthesis of the Antioxidant Glutathione in Neurons: Supply by Astrocytes of CysGly as Precursor for Neuronal Glutathione
1999
7 tesla magnetic resonance imaging: A closer look at substantia nigra anatomy in Parkinson's disease
2014
Works of P. Riederer being referenced
Human cerebral free amino acids in hepatic coma.
1978
An Introduction to neurotransmission in health and disease
1990
Treatment with antioxidants does not prevent loss of dopamine in the striatum of MPTP-treated common marmosets: Preliminary observations
1991
Pharmacology of selegiline
1996
Neue Hypothese zur Ätiopathogenese des Alzheimer-SyndromsAdvanced glycation endproducts (AGEs)
1996
Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease
1992
Direct sequencing of the reserpine-sensitive vesicular monoamine transporter complementary DNA in unipolar depression and manic depressive illness
1994
Mössbauer Spectroscopic Studies of Purified Human Neuromelanin Isolated from the Substantia Nigra
1995
Dopamine D3 receptor gene polymorphism and alcohol dependence
1999
Terguride: partial dopamine agonist in the treatment of Parkinson's disease.
1987
Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties.
1994
Neuropsychopharmacology of the Trace Amines
1985
Long-term behavioural effects of TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) after subchronic treatment in rats.
1995
Ciliary neurotrophic factor (CNTF) genotypes: influence on choline acetyltransferase (ChAT) and acetylcholine esterase (AChE) activities and neurotrophin 3 (NT3) concentration in human post mortem brain tissue.
1997
Glutamatergic-dopaminergic balance in the brain. Its importance in motor disorders and schizophrenia
1992
The role of iron in senescence of dopaminergic neurons in Parkinson's disease.
1993
Parkinson’s Disease: Biochemistry, Clinical Pathology, and Treatment
1983
Iron and ferritin in substantia nigra in Parkinson's disease.
1993